The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Dyer, Nicholas
    Executive born in December 1970
    Individual (2 offsprings)
    Officer
    2019-08-31 ~ dissolved
    OF - director → CIF 0
  • 2
    Hulse, Stewart Oliver
    Director Of European Operation Catalyst Europe born in October 1973
    Individual (1 offspring)
    Officer
    2018-04-02 ~ dissolved
    OF - director → CIF 0
  • 3
    Mcnamara, Patricia Bronke
    Finance Executive born in June 1968
    Individual (2 offsprings)
    Officer
    2019-08-31 ~ dissolved
    OF - director → CIF 0
  • 4
    5th Floor, One New Change, London, United Kingdom
    Corporate (7 parents, 180 offsprings)
    Officer
    2016-09-12 ~ dissolved
    OF - secretary → CIF 0
Ceased 2
parent relation
Company in focus

CATALYST CLINICAL RESEARCH UK, LTD.

Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Debtors
672,684 GBP2021-12-31
975,083 GBP2020-12-31
Cash at bank and in hand
137,300 GBP2021-12-31
55,441 GBP2020-12-31
Current Assets
809,984 GBP2021-12-31
1,030,524 GBP2020-12-31
Creditors
Current, Amounts falling due within one year
-258,420 GBP2021-12-31
-438,554 GBP2020-12-31
Net Current Assets/Liabilities
551,564 GBP2021-12-31
591,970 GBP2020-12-31
Equity
Called up share capital
1 GBP2021-12-31
1 GBP2020-12-31
Retained earnings (accumulated losses)
551,563 GBP2021-12-31
591,969 GBP2020-12-31
Equity
551,564 GBP2021-12-31
591,970 GBP2020-12-31
Average Number of Employees
22021-01-01 ~ 2021-12-31
12020-01-01 ~ 2020-12-31
Property, Plant & Equipment - Gross Cost
Computers
857 GBP2020-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
857 GBP2020-12-31
Property, Plant & Equipment
Computers
0 GBP2021-12-31
0 GBP2020-12-31
Trade Debtors/Trade Receivables
Current
270,861 GBP2021-12-31
310,481 GBP2020-12-31
Amount of corporation tax that is recoverable
Current
9,258 GBP2021-12-31
0 GBP2020-12-31
Amounts Owed by Group Undertakings
Current
208,885 GBP2021-12-31
266,265 GBP2020-12-31
Other Debtors
Current
183,680 GBP2021-12-31
398,337 GBP2020-12-31
Debtors
Current, Amounts falling due within one year
672,684 GBP2021-12-31
975,083 GBP2020-12-31
Trade Creditors/Trade Payables
Current
25,686 GBP2021-12-31
8,572 GBP2020-12-31
Corporation Tax Payable
Current
41,176 GBP2021-12-31
40,864 GBP2020-12-31
Other Creditors
Current
64,235 GBP2021-12-31
333,671 GBP2020-12-31
Accrued Liabilities/Deferred Income
Current
127,323 GBP2021-12-31
55,447 GBP2020-12-31
Creditors
Current
258,420 GBP2021-12-31
438,554 GBP2020-12-31

  • CATALYST CLINICAL RESEARCH UK, LTD.
    Info
    Registered number 10370842
    5th Floor One New Change, London EC4M 9AF
    Private Limited Company incorporated on 2016-09-12 and dissolved on 2024-07-30 (7 years 10 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.